Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • August 2013
  • Teaching Plan
  • HBS Case Collection

Remicade-Simponi

By: Guhan Subramanian and Charlotte Krontiris
  • Format:Print
  • | Language:English
  • | Pages:5
ShareBar

Abstract

This exercise models a negotiation between two pharmaceutical companies—Johnson & Johnson and Merck—concerning the international distribution rights for Remicade, a blockbuster anti-arthritis drug. At odds over the original distribution contract, the two companies enter a final negotiation session before they must take their case to arbitration. This exercise gives students the opportunity to experiment with creative deal structures as a response to a narrow legal dispute.

Keywords

Johnson & Johnson; Merck; Negotiation; Negotiation Participants; Negotiation Deal; Pharmaceutical Industry

Citation

Subramanian, Guhan, and Charlotte Krontiris. "Remicade-Simponi." Harvard Business School Teaching Plan 914-006, August 2013.
  • Purchase

About The Author

Guhan Subramanian

Negotiation, Organizations & Markets
→More Publications

Related Work

    • November 2017
    • Faculty Research

    Remicade-Simponi

    By: Guhan Subramanian
    • May 2018
    • Faculty Research

    Remicade-Simponi: Valuation Supplement

    By: Guhan Subramanian
Related Work
  • Remicade-Simponi By: Guhan Subramanian
  • Remicade-Simponi: Valuation Supplement By: Guhan Subramanian
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.